Xiaolong Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiaolong Guo has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Chengli Zhang
College of Pharmacy, Institute of Life Science and School of Public Health, Chongqing Medical University, Chongqing 400016, PR China
3 shared publications Wei Wang
Information Department Zigong First People's Hospital Zigong China
2 shared publicationsXianglin Luo
Information Department Zigong First People's Hospital Zigong China
2 shared publicationsFuqiang Shao
Zigong First People's Hospital
1 shared publication- Hongli Zhou
Key Laboratory of Tropical Disease Control (Sun Yat‐sen University) Ministry of Education Guangzhou Guangdong 510080 China
1 shared publication - Hongxin Fu
School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 12 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (50) , eady3070
DNA-directed electrochemiluminescence nanosphere with electrocatalysis-enhanced microfluidic arrays for rapid multibacterial detection
Rapid detection of multibacterial pathogens is crucial for accelerating the diagnosis and treatment of bacterial infections. We propose a rapid and efficient electrochemiluminescence (ECL) sensor for the synchronous detection of multiple bacterial pathogens, including Staphylococcus aureus , Klebsiella pneumoniae , Pseudomonas aeruginosa , and methicillin-resistant S. aureus . This homogeneous sensor is based on a self-assembled DNA nanosphere loaded with tetrakis (4-carboxyphenyl) porphyrin (TCPP). The sensor operates in an “off-on” mode, in which bacterium-aptamer binding triggers a conformational change in the DNA nanosphere, releasing TCPP and generating an enhanced ECL signal. The inclusion of cerium nanoparticles boosts signal intensity through electrocatalytic reactions, improving sensitivity with a detection limit of ≤100 colony-forming units per milliliter. Integrated with a microfluidic chip, the system enables multibacterial detection in just 45 minutes. Bacterial quantification in clinical samples strongly correlates with digital polymerase chain reaction results. This approach provides a rapid, specific, and efficient diagnostic tool for bacterial infections with great potential for point-of-care applications in clinical settings.
- 12 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (50) , eady3070
Top Cited PapersOpen AccessDNA-directed electrochemiluminescence nanosphere with electrocatalysis-enhanced microfluidic arrays for rapid multibacterial detection
Rapid detection of multibacterial pathogens is crucial for accelerating the diagnosis and treatment of bacterial infections. We propose a rapid and efficient electrochemiluminescence (ECL) sensor for the synchronous detection of multiple bacterial pathogens, including Staphylococcus aureus , Klebsiella pneumoniae , Pseudomonas aeruginosa , and methicillin-resistant S. aureus . This homogeneous sensor is based on a self-assembled DNA nanosphere loaded with tetrakis (4-carboxyphenyl) porphyrin (TCPP). The sensor operates in an “off-on” mode, in which bacterium-aptamer binding triggers a conformational change in the DNA nanosphere, releasing TCPP and generating an enhanced ECL signal. The inclusion of cerium nanoparticles boosts signal intensity through electrocatalytic reactions, improving sensitivity with a detection limit of ≤100 colony-forming units per milliliter. Integrated with a microfluidic chip, the system enables multibacterial detection in just 45 minutes. Bacterial quantification in clinical samples strongly correlates with digital polymerase chain reaction results. This approach provides a rapid, specific, and efficient diagnostic tool for bacterial infections with great potential for point-of-care applications in clinical settings.
- Open Access
- 12 June 2024
- Published by American Society for Microbiology in mBio
- Vol. 15 (6) , e0061624
Pseudomonas aeruginosa two-component system LadS/PA0034 regulates macrophage phagocytosis via fimbrial protein cupA1
Pseudomonas aeruginosa is one of the most common nosocomial pathogens worldwide, known for its virulence, drug resistance, and elaborate sensor-response network. The primary challenge encountered by pathogens during the initial stages of infection is the immune clearance arising from the host. The resident macrophages of barrier organs serve as the frontline defense against these pathogens. Central to our understanding is the mechanism by which bacteria modify their behavior to circumvent macrophage-mediated clearance, ensuring their persistence and colonization. To successfully evade macrophage-mediated phagocytosis, bacteria must possess an adaptive response mechanism. Two-component systems provide bacteria the agility to navigate diverse environmental challenges, translating external stimuli into cellular adaptive responses. Here, we report that the well-documented histidine kinase, LadS, coupled to a cognate two-component response regulator, PA0034, governs the expression of a vital adhesin called chaperone-usher pathway pilus cupA. The LadS/PA0034 system is susceptible to interference from the reactive oxygen species likely to be produced by macrophages and further lead to a poor adhesive phenotype with scantily cupA pilus, impairing the phagocytosis efficiency of macrophages during acute infection. This dynamic underscores the intriguing interplay: as macrophages deploy reactive oxygen species to combat bacterial invasion, the bacteria recalibrate their exterior to elude these defenses. IMPORTANCE: The notoriety of Pseudomonas aeruginosa is underscored by its virulence, drug resistance, and elaborate sensor-response network. Yet, the mechanisms by which P. aeruginosa maneuvers to escape phagocytosis during acute infections remain elusive. This study pinpoints a two-component response regulator, PA0034, coupled with the histidine kinase LadS, and responds to macrophage-derived reactive oxygen species. The macrophage-derived reactive oxygen species can impair the LadS/PA0034 system, resulting in reduced expression of cupA pilus in the exterior of P. aeruginosa . Since the cupA pilus is an important adhesin of P. aeruginosa , its deficiency reduces bacterial adhesion and changes their behavior to adopt a planktonic lifestyle, subsequently inhibiting the phagocytosis of macrophages by interfering with bacterial adhesion. Briefly, reactive oxygen species may act as environmental cues for the LadS/PA0034 system. Upon recognition, P. aeruginosa may transition to a poorly adhesive state, efficiently avoiding engulfment by macrophages.
- 12 June 2024
- Published by American Society for Microbiology in mBio
- Vol. 15 (6) , e0061624
Open AccessPseudomonas aeruginosa two-component system LadS/PA0034 regulates macrophage phagocytosis via fimbrial protein cupA1
Pseudomonas aeruginosa is one of the most common nosocomial pathogens worldwide, known for its virulence, drug resistance, and elaborate sensor-response network. The primary challenge encountered by pathogens during the initial stages of infection is the immune clearance arising from the host. The resident macrophages of barrier organs serve as the frontline defense against these pathogens. Central to our understanding is the mechanism by which bacteria modify their behavior to circumvent macrophage-mediated clearance, ensuring their persistence and colonization. To successfully evade macrophage-mediated phagocytosis, bacteria must possess an adaptive response mechanism. Two-component systems provide bacteria the agility to navigate diverse environmental challenges, translating external stimuli into cellular adaptive responses. Here, we report that the well-documented histidine kinase, LadS, coupled to a cognate two-component response regulator, PA0034, governs the expression of a vital adhesin called chaperone-usher pathway pilus cupA. The LadS/PA0034 system is susceptible to interference from the reactive oxygen species likely to be produced by macrophages and further lead to a poor adhesive phenotype with scantily cupA pilus, impairing the phagocytosis efficiency of macrophages during acute infection. This dynamic underscores the intriguing interplay: as macrophages deploy reactive oxygen species to combat bacterial invasion, the bacteria recalibrate their exterior to elude these defenses. IMPORTANCE: The notoriety of Pseudomonas aeruginosa is underscored by its virulence, drug resistance, and elaborate sensor-response network. Yet, the mechanisms by which P. aeruginosa maneuvers to escape phagocytosis during acute infections remain elusive. This study pinpoints a two-component response regulator, PA0034, coupled with the histidine kinase LadS, and responds to macrophage-derived reactive oxygen species. The macrophage-derived reactive oxygen species can impair the LadS/PA0034 system, resulting in reduced expression of cupA pilus in the exterior of P. aeruginosa . Since the cupA pilus is an important adhesin of P. aeruginosa , its deficiency reduces bacterial adhesion and changes their behavior to adopt a planktonic lifestyle, subsequently inhibiting the phagocytosis of macrophages by interfering with bacterial adhesion. Briefly, reactive oxygen species may act as environmental cues for the LadS/PA0034 system. Upon recognition, P. aeruginosa may transition to a poorly adhesive state, efficiently avoiding engulfment by macrophages.
- Open Access
- 22 January 2024
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 12 (1) , e1158
Effect of serum inflammatory factors in predicting co‐infection with influenza viruses and Omicron
Objectives: To identify the key differences in laboratory indicators between mono‐infection and co‐infection by influenza viruses and Omicron to facilitate timely adjustments in patient treatment strategies.Methods: Prealbumin and C‐reactive protein (CRP) levels were analyzed in 161 COVID‐19 cases infected by SARS‐CoV‐2 (wild type), 299 cases infected by Omicron, 95 cases infected by influenza virus A/B (Flu A/B) and 133 co‐infection cases infected with Flu A/B and Omicron. The receiver operating characteristic (ROC) curve and logistic regression equation were used to analyze the clinical predictive capacity of prealbumin and CRP in coinfected patients.Results: The co‐infected and wild‐type infected patients had significantly different CRP and prealbumin levels compared to mono‐infected patients with Omicron or Flu A/B (p < .001). The ROC curve results indicated that prealbumin was more efficient than CRP in identifying co‐infection from Omicron (AUC: 0.867 vs. 0.724) or Flu A/B (AUC: 0.797 vs. 0.730), and joint prediction significantly improved the diagnostic ability to discriminate co‐infection from mono‐infection (AUC: 0.934 and 0.887).Conclusion: The findings suggest that prealbumin is a valuable indicator that can warn of co‐infection and guide timely treatment decisions. Joint prediction may offer an even more effective diagnostic tool for discriminating co‐infection from mono‐infection.
- 22 January 2024
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 12 (1) , e1158
Open AccessEffect of serum inflammatory factors in predicting co‐infection with influenza viruses and Omicron
Objectives: To identify the key differences in laboratory indicators between mono‐infection and co‐infection by influenza viruses and Omicron to facilitate timely adjustments in patient treatment strategies.Methods: Prealbumin and C‐reactive protein (CRP) levels were analyzed in 161 COVID‐19 cases infected by SARS‐CoV‐2 (wild type), 299 cases infected by Omicron, 95 cases infected by influenza virus A/B (Flu A/B) and 133 co‐infection cases infected with Flu A/B and Omicron. The receiver operating characteristic (ROC) curve and logistic regression equation were used to analyze the clinical predictive capacity of prealbumin and CRP in coinfected patients.Results: The co‐infected and wild‐type infected patients had significantly different CRP and prealbumin levels compared to mono‐infected patients with Omicron or Flu A/B (p < .001). The ROC curve results indicated that prealbumin was more efficient than CRP in identifying co‐infection from Omicron (AUC: 0.867 vs. 0.724) or Flu A/B (AUC: 0.797 vs. 0.730), and joint prediction significantly improved the diagnostic ability to discriminate co‐infection from mono‐infection (AUC: 0.934 and 0.887).Conclusion: The findings suggest that prealbumin is a valuable indicator that can warn of co‐infection and guide timely treatment decisions. Joint prediction may offer an even more effective diagnostic tool for discriminating co‐infection from mono‐infection.
- Open Access
- 7 March 2023
- Published by Wiley
Effect of serum inflammatory factors in predicting co-infection with influenza viruses and Omicron
A document by Chengli Zhang. Click on the document to view its contents.
- 7 March 2023
- Published by Wiley
Open AccessEffect of serum inflammatory factors in predicting co-infection with influenza viruses and Omicron
A document by Chengli Zhang. Click on the document to view its contents.
- 7 July 2021
- Published by Springer Nature in Bioprocess and Biosystems Engineering
- Vol. 44 (11) , 2375-2385
Isolation and characterization of a newly identified Clostridium butyricum strain SCUT343-4 for 1,3-propanediol production
A novel 1,3-propanediol (1,3-PDO) producing strain was isolated and identified as Clostridium butyricum with respect to its morphological and physiological characteristics, as well as 16S rDNA. The results of substrates test and stress tolerance indicated that C. butyricum SCUT343-4 could produce 1,3-PDO efficiently from glycerol. The optimal fermentation conditions were determined to be 5 g/L yeast extract at 37 °C and pH 6.5. To fully evaluate its 1,3-PDO production capacity, different cultivation strategies have been implemented. The highest 1,3-PDO concentration obtained for batch and fed-batch fermentation were 51.64 and 61.30 g/L, respectively. Immobilized cell fermentation in fibrous-bed bioreactor was also performed, and the concentration of 1,3-PDO further increased to 86 g/L with a yield of 0.52 g/g. In addition, the 1,3-PDO productivity reached 4.20 g/L h, which is the highest level reported for C. butyricum, demonstrating the potential of C. butyricum SCUT343-4 for 1,3-PDO production from glycerol.
- 7 July 2021
- Published by Springer Nature in Bioprocess and Biosystems Engineering
- Vol. 44 (11) , 2375-2385
Isolation and characterization of a newly identified Clostridium butyricum strain SCUT343-4 for 1,3-propanediol production
A novel 1,3-propanediol (1,3-PDO) producing strain was isolated and identified as Clostridium butyricum with respect to its morphological and physiological characteristics, as well as 16S rDNA. The results of substrates test and stress tolerance indicated that C. butyricum SCUT343-4 could produce 1,3-PDO efficiently from glycerol. The optimal fermentation conditions were determined to be 5 g/L yeast extract at 37 °C and pH 6.5. To fully evaluate its 1,3-PDO production capacity, different cultivation strategies have been implemented. The highest 1,3-PDO concentration obtained for batch and fed-batch fermentation were 51.64 and 61.30 g/L, respectively. Immobilized cell fermentation in fibrous-bed bioreactor was also performed, and the concentration of 1,3-PDO further increased to 86 g/L with a yield of 0.52 g/g. In addition, the 1,3-PDO productivity reached 4.20 g/L h, which is the highest level reported for C. butyricum, demonstrating the potential of C. butyricum SCUT343-4 for 1,3-PDO production from glycerol.